Home>Topics>Companies>Henry Schein

Henry Schein HSIC

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
    1. Idexx drops Schein

      Headlines

      Fri, 25 Jul 2014

      Idexx Laboratories (NASDAQ: IDXX ) informs distributor Henry Schein (NASDAQ: HSIC ) that it intends to sell its vet diagnostic products directly in the U.S. effective January 1, 2015. This

    2. New Morningstar Analyst Report for Henry Schein Inc

      Stock Reports

      Tue, 24 Jun 2014

      term shareholder interests. Henry Schein distributes health care products ..... operating and financial risk at Henry Schein is limited. Schein's scale helps ..... maintaining our fair value estimate for Henry Schein at $105 per share, which implies

    3. Patterson’s Results Slump on Weather and Dental Equipment Headwinds

      Commentary

      Thu, 22 May 2014

      We found the 4.7% decline in dental equipment sales particularly surprising this quarter, which, in light of Henry Schein ’s recent gains in this market, suggests Patterson is losing market share. We speculate Patterson’s CEREC CAD

    4. Harsh Weather Temporarily Slows Henry Schein's Momentum

      Commentary

      Tue, 6 May 2014

      This year’s harsh winter had an expected cooling effect on Henry Schein ’s performance during the company’s first quarter. Management estimates that the negative weather effect depressed total growth

    5. Schein Posts Strong Fourth-Quarter Results Despite Difficult Year-Over-Year Comparisons

      Commentary

      Tue, 11 Feb 2014

      We’re leaving our $105 fair value estimate and wide moat rating for Henry Schein unchanged after the company’s fourth-quarter results met our expectations. Excluding seasonal differences from the flu and

    6. Patterson Maintains Outlook With Better Second-Half Performance Expected

      Commentary

      Thu, 21 Nov 2013

      thanks to pent-up demand, in our view. However, Patterson's growth continues to that of its main competitor, Henry Schein , in the U.S. dental market, which also suggests Patterson might be yielding potential market share gains from smaller

    7. Schein Previews Double-Digit Earnings Growth for 2014 as Global Economic Headwinds Persist

      Commentary

      Tue, 5 Nov 2013

      We don’t plan to change our $99 fair value estimate for Henry Schein , as the company remains on track to meet our year-end expectations after its third-quarter results. Additionally, our 2014

    8. Unique Characteristics in Dental and Veterinary Distributor Markets Support Wide Economic Moats

      Headlines

      Fri, 5 Jul 2013

      We have upgraded Henry Schein HSIC and Patterson Companies PDCO to wide-moat companies thanks to their strong competitive advantages in the dental and veterinary

    9. Upgrading Patterson's and Henry Schein's Moats to Wide

      Commentary

      Mon, 17 Jun 2013

      We have upgraded Henry Schein HSIC and Patterson PDCO to wide-moat companies thanks to their strong competitive advantages in the dental and veterinary distribution

    10. Schein's Domestic Business Offsets Weak International Results

      Commentary

      Tue, 7 May 2013

      We plan to raise our fair value estimate for Henry Schein HSIC as we transfer coverage to a new analyst. In the first quarter, Schein reported 9.3% revenue growth, which includes

    « Prev12345Next »
    Content Partners